Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eloit

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
The Veterinary Record|January 28, 1989
Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virusM Eloit, D Fargeaud, P Vannier, et al.
Archives of Virology|January 1, 1992
Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virusM Eloit, P Vannier, E Hutet, et al.
Neuroscience|July 18, 2006
Axotomy-induced motoneuron death is delayed in mice overexpressing PrPcM Coulpier, S Messiaen, D Boucreaux, et al.
Vaccine|August 1, 1996
Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in miceP Gonin, W Oualikene, A Fournier, et al.
Archives of Virology|January 1, 1988
Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodiesM Eloit, D Fargeaud, R L'Haridon, et al.
Research in Veterinary Science|January 1, 1990
Detection of Aujeszky's disease virus in nasal cells of fattening pigs by immunoassayA Jestin, M Onno, M Eloit, et al.
The Journal of General Virology|October 1, 1990
Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccineM Eloit, P Gilardi-Hebenstreit, B Toma, et al.
Virologie (Montrouge, France)|April 4, 2023
[Encephalomyocarditis virus]S Hammoumi, M Guy, M Eloit, et al.
Vaccine|October 1, 1994
Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvantsV Ganne, M Eloit, A Laval, et al.
Virology|December 24, 1997
Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cellsA Ambriović, M Adam, M Monteil, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
The Veterinary Record|January 28, 1989
Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virusM Eloit, D Fargeaud, P Vannier, et al.
Archives of Virology|January 1, 1992
Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virusM Eloit, P Vannier, E Hutet, et al.
Neuroscience|July 18, 2006
Axotomy-induced motoneuron death is delayed in mice overexpressing PrPcM Coulpier, S Messiaen, D Boucreaux, et al.
Vaccine|August 1, 1996
Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in miceP Gonin, W Oualikene, A Fournier, et al.
Archives of Virology|January 1, 1988
Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodiesM Eloit, D Fargeaud, R L'Haridon, et al.
Research in Veterinary Science|January 1, 1990
Detection of Aujeszky's disease virus in nasal cells of fattening pigs by immunoassayA Jestin, M Onno, M Eloit, et al.
The Journal of General Virology|October 1, 1990
Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccineM Eloit, P Gilardi-Hebenstreit, B Toma, et al.
Virologie (Montrouge, France)|April 4, 2023
[Encephalomyocarditis virus]S Hammoumi, M Guy, M Eloit, et al.
Vaccine|October 1, 1994
Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvantsV Ganne, M Eloit, A Laval, et al.
Virology|December 24, 1997
Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cellsA Ambriović, M Adam, M Monteil, et al.
Pageof 9